IRWD Return on Tangible Equity | IRONWOOD PHARMACEUTICALS, INC.

IRONWOOD PHARMACEUTICALS, INC. (IRWD) Return on Tangible Equity

2026-06-30: Return Tang Equity -79.06%.
2026-03-31: Return Tang Equity -46.49%.
2025-12-31: Return Tang Equity -9.07%.
2025-09-30: Return Tang Equity -10.68%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-79.06%
2026-03-31	-46.49%
2025-12-31	-9.07%
2025-09-30	-10.68%
2025-06-30	2.53%
2025-03-31	9.58%
2024-12-31	-0.29%
2024-09-30	0.78%
2024-06-30	-2.83%
2024-03-31	314.27%
2023-12-31	285.73%
2023-09-30	290.43%
2023-06-30	261.65%
2023-03-31	32.90%
2022-12-31	35.11%
2022-09-30	38.32%
2022-06-30	45.66%
2022-03-31	144.85%
2021-12-31	116.87%
2021-09-30	124.42%
2021-06-30	142.13%
2021-03-31	-327.83%
2020-12-31	-116.55%
2020-09-30	-74.97%
2020-06-30	-50.92%
2020-03-31	-37.34%
2019-12-31	-8.71%
2019-09-30	13.64%
2019-06-30	63.48%
2019-03-31	76.36%
2018-12-31	80.65%
2018-09-30	72.58%
2018-06-30	57.03%
2018-03-31	61.38%
2017-12-31	77.52%
2017-09-30	776.12%
2017-06-30	-3511.24%
2017-03-31	-419.08%
2016-12-31	-197.46%
2016-09-30	-272.98%
2016-06-30	-98.72%
2013-09-30	-77.15%
2012-12-31	-16.54%
2012-09-30	0.65%
2011-12-31	-52.89%
2011-09-30	-51.25%
2011-06-30	-41.79%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-9.07%
2024-12-31	-0.29%
2023-12-31	285.73%
2022-12-31	35.60%
2021-12-31	118.69%
2020-12-31	-108.29%
2019-12-31	-8.47%
2018-12-31	79.08%
2017-12-31	77.52%
2016-12-31	-123.93%
2015-12-31	-149.98%
2012-12-31	-50.42%
2011-12-31	-59.03%
2010-12-31	-32.50%
2009-12-31	24.57%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Nuvectis Pharma, Inc. (NVCT)	United States	$0.705B	-17.53
Climb Bio, Inc. (CLYM)	United States	$0.683B	-13.03
Verastem, Inc. (VSTM)	United States	$0.706B	-1.71
ZEVRA THERAPEUTICS, INC. (ZVRA)	United States	$0.668B	14.61
COLLEGIUM PHARMACEUTICAL, INC (COLL)	United States	$0.737B	24.57
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
Faeth Therapeutics, Inc. (FTH)	United States	$0.750B
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
Neurogene Inc. (NGNE)		$0.625B	-4.46
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78